Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics

Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics

The assays, methods, tools and systems discussed herein represent an improved and unified system for monitoring the progression of an individual patient malignancy. The assays, methods, tools and systems discussed herein represent an improved and unified system for monitoring and for identifying cel...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Gabrin, Michael, Brower, Stacey, McDonald, Sean, Gallion, Holly, Nanavati, Payal, Rice, Shara Dawn, Chattopadhyay, Anuja
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Gabrin, Michael
Brower, Stacey
McDonald, Sean
Gallion, Holly
Nanavati, Payal
Rice, Shara Dawn
Chattopadhyay, Anuja
description The assays, methods, tools and systems discussed herein represent an improved and unified system for monitoring the progression of an individual patient malignancy. The assays, methods, tools and systems discussed herein represent an improved and unified system for monitoring and for identifying cellular and secreted markers, for screening cells to detect phenotypic and genotypic drift and for predicting chemotherapeutic response of patient tumor cells to at least one therapeutic agent. The assays, methods, tools and systems discussed herein also represent an improved and unified system for monitoring and for screening multiple pharmaceutical agents for efficacy and long term effect as to a specific patient.
format Patent
fullrecord <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07642048</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07642048</sourcerecordid><originalsourceid>FETCH-uspatents_grants_076420483</originalsourceid><addsrcrecordid>eNqNi0EKwkAQBHPxIOof5gOBoEG9h4gP8OZBxmXMDiS7y_ZEzO9NwAd4KqiuXhf3xssQS0iAmr7VJmKAJ9AIDR3ZOMRMTvoeJB-vz7madZIMhUkwSl5CtCmpI-c5szPJ86QO22L14h6y-3FT0KW9NddyROLli0eXeUF1Otb7qj4f_ki--Bc-EQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics</title><source>USPTO Issued Patents</source><creator>Gabrin, Michael ; Brower, Stacey ; McDonald, Sean ; Gallion, Holly ; Nanavati, Payal ; Rice, Shara Dawn ; Chattopadhyay, Anuja</creator><creatorcontrib>Gabrin, Michael ; Brower, Stacey ; McDonald, Sean ; Gallion, Holly ; Nanavati, Payal ; Rice, Shara Dawn ; Chattopadhyay, Anuja ; Precision Therapeutics Inc</creatorcontrib><description>The assays, methods, tools and systems discussed herein represent an improved and unified system for monitoring the progression of an individual patient malignancy. The assays, methods, tools and systems discussed herein represent an improved and unified system for monitoring and for identifying cellular and secreted markers, for screening cells to detect phenotypic and genotypic drift and for predicting chemotherapeutic response of patient tumor cells to at least one therapeutic agent. The assays, methods, tools and systems discussed herein also represent an improved and unified system for monitoring and for screening multiple pharmaceutical agents for efficacy and long term effect as to a specific patient.</description><language>eng</language><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7642048$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,802,885,64039</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7642048$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Gabrin, Michael</creatorcontrib><creatorcontrib>Brower, Stacey</creatorcontrib><creatorcontrib>McDonald, Sean</creatorcontrib><creatorcontrib>Gallion, Holly</creatorcontrib><creatorcontrib>Nanavati, Payal</creatorcontrib><creatorcontrib>Rice, Shara Dawn</creatorcontrib><creatorcontrib>Chattopadhyay, Anuja</creatorcontrib><creatorcontrib>Precision Therapeutics Inc</creatorcontrib><title>Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics</title><description>The assays, methods, tools and systems discussed herein represent an improved and unified system for monitoring the progression of an individual patient malignancy. The assays, methods, tools and systems discussed herein represent an improved and unified system for monitoring and for identifying cellular and secreted markers, for screening cells to detect phenotypic and genotypic drift and for predicting chemotherapeutic response of patient tumor cells to at least one therapeutic agent. The assays, methods, tools and systems discussed herein also represent an improved and unified system for monitoring and for screening multiple pharmaceutical agents for efficacy and long term effect as to a specific patient.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNqNi0EKwkAQBHPxIOof5gOBoEG9h4gP8OZBxmXMDiS7y_ZEzO9NwAd4KqiuXhf3xssQS0iAmr7VJmKAJ9AIDR3ZOMRMTvoeJB-vz7madZIMhUkwSl5CtCmpI-c5szPJ86QO22L14h6y-3FT0KW9NddyROLli0eXeUF1Otb7qj4f_ki--Bc-EQ</recordid><startdate>20100105</startdate><enddate>20100105</enddate><creator>Gabrin, Michael</creator><creator>Brower, Stacey</creator><creator>McDonald, Sean</creator><creator>Gallion, Holly</creator><creator>Nanavati, Payal</creator><creator>Rice, Shara Dawn</creator><creator>Chattopadhyay, Anuja</creator><scope>EFH</scope></search><sort><creationdate>20100105</creationdate><title>Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics</title><author>Gabrin, Michael ; Brower, Stacey ; McDonald, Sean ; Gallion, Holly ; Nanavati, Payal ; Rice, Shara Dawn ; Chattopadhyay, Anuja</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_076420483</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2010</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Gabrin, Michael</creatorcontrib><creatorcontrib>Brower, Stacey</creatorcontrib><creatorcontrib>McDonald, Sean</creatorcontrib><creatorcontrib>Gallion, Holly</creatorcontrib><creatorcontrib>Nanavati, Payal</creatorcontrib><creatorcontrib>Rice, Shara Dawn</creatorcontrib><creatorcontrib>Chattopadhyay, Anuja</creatorcontrib><creatorcontrib>Precision Therapeutics Inc</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Gabrin, Michael</au><au>Brower, Stacey</au><au>McDonald, Sean</au><au>Gallion, Holly</au><au>Nanavati, Payal</au><au>Rice, Shara Dawn</au><au>Chattopadhyay, Anuja</au><aucorp>Precision Therapeutics Inc</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics</title><date>2010-01-05</date><risdate>2010</risdate><abstract>The assays, methods, tools and systems discussed herein represent an improved and unified system for monitoring the progression of an individual patient malignancy. The assays, methods, tools and systems discussed herein represent an improved and unified system for monitoring and for identifying cellular and secreted markers, for screening cells to detect phenotypic and genotypic drift and for predicting chemotherapeutic response of patient tumor cells to at least one therapeutic agent. The assays, methods, tools and systems discussed herein also represent an improved and unified system for monitoring and for screening multiple pharmaceutical agents for efficacy and long term effect as to a specific patient.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_grants_07642048
source USPTO Issued Patents
title Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T10%3A38%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Gabrin,%20Michael&rft.aucorp=Precision%20Therapeutics%20Inc&rft.date=2010-01-05&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07642048%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true